Non-specific and paradoxical effects of neo-adjuvant PS341 after radical prostatectomy in high-risk patients

被引：0
|
作者：
Ayala, G [1 ]
Li, R [1 ]
Thompson, TC [1 ]
Lynch, GR [1 ]
Mims, MP [1 ]
Frolov, A [1 ]
Hayes, T [1 ]
Wheeler, T [1 ]
Miles, BJ [1 ]
Kadmon, D [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
588
引用
收藏
页码：129A / 129A
页数：1
相关论文
共 50 条
  • [1] Non-specific and paradoxical effects of neo-adjuvant PS341 after radical prostatectomy in high-risk patients
    Ayala, GE
    Li, R
    Thompson, TC
    Lynch, GR
    Mims, MP
    Frolov, A
    Hayes, T
    Wheeler, TM
    Miles, BJ
    Kadmon, D
    MODERN PATHOLOGY, 2006, 19 : 129A - 129A
  • [2] THE EFFECT OF NEO-ADJUVANT CHEMOTHERAPY ON RADICAL PROSTATECTOMY OUTCOMES IN INTERMEDIATE AND HIGH-RISK PROSTATE CANCER
    Kang, Taejin
    Kim, Wansuk
    Lee, Jungmin
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    JOURNAL OF UROLOGY, 2010, 183 (04): : E230 - E231
  • [3] Adjuvant weekly docetaxel for high-risk prostate cancer patients after radical prostatectomy
    Kibel, AS
    Kattan, MW
    Picus, J
    Dreicer, R
    Klein, EA
    Wilding, G
    Jarrard, DF
    Roth, B
    Cookson, MS
    Pettylak, DP
    Chatta, G
    Nelson, JB
    Beer, TM
    Dipaola, R
    Partin, AI
    Rosenbaum, E
    Garrett, E
    Sugar, E
    Eisenberger, M
    JOURNAL OF UROLOGY, 2006, 175 (04): : 512 - 512
  • [4] Adjuvant weekly docetaxel for high-risk prostate cancer patients after Radical Prostatectomy
    Kibel, AS
    Picus, J
    Cookson, MS
    Roth, B
    Jarrard, DF
    Wilding, G
    Klein, EA
    Dreicer, R
    Nelson, JB
    Chatta, G
    Benson, MC
    Petrylak, DP
    DiPaola, R
    Beer, TM
    Diamond, J
    Partin, AW
    Eisenberger, MA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 222 - 222
  • [5] ADJUVANT RADIOTHERAPY FOR HIGH-RISK PATIENTS AFTER RADICAL PROSTATECTOMY: BENEFITS AND TOXICITY IN OUR EXPERIENCE
    Spagnoletti, Girolamo
    Marchese, Rita
    Nardella, Grazia
    Oriolo, Vincenzo
    De Nobili, Giuseppe
    Bove, Giuseppe
    ANTICANCER RESEARCH, 2011, 31 (05) : 1886 - 1886
  • [6] Neo-adjuvant 177Lu-PSMA-I&T radionuclide in high-risk prostate cancer before radical prostatectomy: A feasibility trial
    Frumer, M.
    Rosenbaum, E.
    Kedar, D.
    Zohar, Y.
    Baniel, J.
    Steinmetz, A.
    Bernstine, H.
    Groshar, D.
    Golan, S.
    EUROPEAN UROLOGY, 2021, 79 : S1705 - S1705
  • [7] NEO-ADJUVANT 177LU-PSMA-I&T RADIONUCLIDE IN HIGH-RISK PROSTATE CANCER BEFORE RADICAL PROSTATECTOMY: A FEASIBILITY TRIAL
    Frumer, Michael
    Rosenbaum, Eli
    Kedar, Daniel
    Zohar, Yarden
    Baniel, Jack
    Steinmetz, Adam
    Bernstine, Hanna
    Groshar, David
    Golan, Shay
    JOURNAL OF UROLOGY, 2021, 206 : E271 - E271
  • [8] AUO Adjuvant therapy in high-risk prostate cancer after radical prostatectomy
    Rexer, H.
    Boegemann, M.
    Graefen, M.
    UROLOGIE, 2022, 61 (06): : 705 - 706
  • [9] Radical prostatectomy following neo-adjuvant chemo-hormonal therapy for high-risk or locally advanced prostate cancer: A phase I/II study.
    Konety, BR
    Eastham, J
    Scardino, PT
    Donat, SM
    Dalbagni, G
    Russo, P
    Herr, HW
    Scher, H
    Kelly, WK
    JOURNAL OF UROLOGY, 2002, 167 (04): : 306 - 306
  • [10] Carcinologic outcomes after radical prostatectomy in 81 high-risk patients
    Carcenac, A.
    Arroua, F.
    Gaudart, J.
    Ragni, E.
    Rossi, D.
    Bastide, C.
    PROGRES EN UROLOGIE, 2010, 20 (05): : 356 - 363
12345